Arbovax Company

Arbovax engages in the preclinical and clinical development of vaccine products for the prophylactic treatment of arthropod-borne diseases.
Technology: Cancer
Industry: PharmTech
Headquarters: Raleigh, North Carolina, United States
Founded Date: 2005
Employees Number: 1-10
Estimated Revenue: $1M to $10M

Visit Website
http://twitter.com/arbovax
Register and Claim Ownership